These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2530184)

  • 1. Retargeting of T-cell-receptor gamma/delta+ lymphocytes against tumor cells by bispecific monoclonal antibodies. Induction of cytolytic activity and lymphokine production.
    Ferrini S; Prigione I; Mammoliti S; Colnaghi MI; Menard S; Moretta A; Moretta L
    Int J Cancer Suppl; 1989; 4():53-5. PubMed ID: 2530184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-targeting of human lymphocytes expressing the T-cell receptor gamma/delta to ovarian carcinoma cells by the use of bispecific monoclonal antibodies.
    Ferrini S; Prigione I; Mammoliti S; Colnaghi MI; Ménard S; Moretta A; Moretta L
    Int J Cancer; 1989 Aug; 44(2):245-50. PubMed ID: 2527207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones.
    Ferrini S; Prigione I; Miotti S; Ciccone E; Cantoni C; Chen Q; Colnaghi MI; Moretta L
    Int J Cancer; 1991 May; 48(2):227-33. PubMed ID: 1826900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
    Moretta A; Poggi A; Pende D; Tripodi G; Orengo AM; Pella N; Augugliaro R; Bottino C; Ciccone E; Moretta L
    J Exp Med; 1991 Dec; 174(6):1393-8. PubMed ID: 1720808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering molecules.
    Ferrini S; Cambiaggi A; Cantoni C; Canevari S; Mezzanzanica D; Colnaghi MI; Moretta L
    Int J Cancer Suppl; 1992; 7():15-8. PubMed ID: 1428398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human ovarian carcinoma lysis by cytotoxic T cells targeted by bispecific monoclonal antibodies: analysis of the antibody components.
    Mezzanzanica D; Canevari S; Ménard S; Pupa SM; Tagliabue E; Lanzavecchia A; Colnaghi MI
    Int J Cancer; 1988 Apr; 41(4):609-15. PubMed ID: 3258590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies which react with the T cell receptor gamma/delta recognize different subsets of CD3+WT31- T lymphocytes.
    Ferrini S; Prigione I; Bottino C; Ciccone E; Tambussi G; Mammoliti S; Moretta L; Moretta A
    Eur J Immunol; 1989 Jan; 19(1):57-61. PubMed ID: 2784109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bispecific-monoclonal-antibody-directed lysis of ovarian carcinoma cells by activated human T lymphocytes.
    Möller SA; Reisfeld RA
    Cancer Immunol Immunother; 1991; 33(4):210-6. PubMed ID: 1647871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and cellular analysis of human T lymphocytes expressing gamma delta T-cell receptor.
    Moretta L; Ciccone E; Ferrini S; Pelicci PG; Mingari MC; Zeromski J; Bottino C; Grossi C; Moretta A
    Immunol Rev; 1991 Apr; 120():117-35. PubMed ID: 1650757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW; Kaper BP; Fitch FW
    J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human thymocytes expressing gamma/delta T-cell receptors.
    Mingari MC; Varese P; Bottino C; Tambussi G; Moretta L
    Int J Cancer Suppl; 1989; 4():39-42. PubMed ID: 2530183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
    Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
    Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of "T" lymphocytes against human hepatoma cells by a bispecific monoclonal antibody: role of different lymphocyte subsets.
    Chen Q; Sun P; Prigione I; Xie H; Ferrini S
    Tumori; 1992 Apr; 78(2):79-86. PubMed ID: 1326141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T lymphocytes expressing gamma/delta T cell antigen receptor.
    Moretta L; Ciccone E; Mingari MC; Bottino C; Ferrini S; Tambussi G; Melioli G; Grossi CE; Moretta A
    Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S117-23. PubMed ID: 2521314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective activation of helper and cytolytic T-cell functions of L3T4+ clones with either antireceptor antibody or phorbol ester and ionophore.
    Ju ST; DeKruyff RH; Dorf ME
    Cell Immunol; 1987 May; 106(2):260-72. PubMed ID: 2952285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ovarian carcinoma anti-T3 heteroconjugates or hybrid antibodies induce tumor cell lysis by cytotoxic T-cells.
    Canevari S; Ménard S; Mezzanzanica D; Miotti S; Pupa SM; Lanzavecchia A; Colnaghi MI
    Int J Cancer Suppl; 1988; 2():18-21. PubMed ID: 3258291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
    Coney LR; Mezzanzanica D; Sanborn D; Casalini P; Colnaghi MI; Zurawski VR
    Cancer Res; 1994 May; 54(9):2448-55. PubMed ID: 7512887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective activation of gamma/delta + T cell clones by single anti-CD2 antibodies.
    Wesselborg S; Janssen O; Pechhold K; Kabelitz D
    J Exp Med; 1991 Feb; 173(2):297-304. PubMed ID: 1703204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of tumor-cell lysis by bi-specific monoclonal antibodies recognizing renal-cell carcinoma and CD3 antigen.
    van Dijk J; Warnaar SO; van Eendenburg JD; Thienpont M; Braakman E; Boot JH; Fleuren GJ; Bolhuis RL
    Int J Cancer; 1989 Feb; 43(2):344-9. PubMed ID: 2521843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic activity and lymphokine production of T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ cytotoxic T lymphocyte (CTL) clones recognizing HLA-A2 and HLA-A2 mutants. Recognition of TCR-gamma delta+ CTL clones is affected by mutations at positions 152 and 156.
    Spits H; Paliard X; Engelhard VH; de Vries JE
    J Immunol; 1990 Jun; 144(11):4156-62. PubMed ID: 2111341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.